福建基诺厚普生物科技有限公司成立于2019年1月,由世界500强企业新希望集团厚新健投与台湾扬生物技术公司共同合资建设,是海峡两岸生技和医疗健康产业合作区”*示范项目,是福建省首家具有美国GMP的无菌注射剂药企,产品专注于包括全合成与半合成半发酵多肽类药,现主推原料药产品:司美格鲁肽、替尔泊肽。
What does 福建基诺厚普生物科技有限公司 require? Who is 基诺厚普 hiring? 基诺厚普 recruitment: 工厂生产类占比最多占21.3%,其次是生物/制药/化工/环保类占20.1%. What education can get in at 基诺厚普? 本科占比最多占62.6%,其次是大专占31%. High education required at 基诺厚普? 硕士占2.9%. Work experience required at 基诺厚普? 3-5年占比最多占39.1%,其次是5-10年占28.2%. Where are the job locations at 基诺厚普? 莆田占比最多占92%,其次是泉州占3.4%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows